A downtrend has been apparent in Mesoblast Limited (MESO) lately. While the stock has lost 10.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

We recently published 7 Best ASX Stocks to Buy Right Now. Mesoblast Limited (NASDAQ:MESO) is one of the best ASX stocks. Mesoblast Limited (NASDAQ:MESO) is a biotechnology company developing ...

The average one-year price target for Mesoblast Limited - Depositary Receipt (NasdaqGS:MESO) has been revised to $20.25 / share. This is an increase of 11.48% from the prior estimate of $18.16 dated ...

Mesoblast's remestemcel (Ryoncil) is FDA-approved for steroid-refractory acute graft-versus-host disease in patients two months and older, marking a significant milestone for MSC therapies in the US.

Mesoblast Limited is advancing innovative cellular therapies, with Remestemcel-L for pediatric SR-aGVHD nearing FDA approval and a PDUFA date set for January 2025. Positive Phase 3 results indicate ...

HOUSTON, Dec. 19, 2025 /PRNewswire/ -- Mesothelioma isn't just a diagnosis—it's a life-altering event that can quickly turn the lives of families, caregivers, and entire communities upside down. This ...

I remember when Meso Maya opened near downtown nearly eight years ago: There was hype. Walking in on a Sunday morning for brunch in 2020, that appears to still be the case. You’re asked if you have a ...